BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31729088)

  • 1. Low immune index correlates with favorable prognosis but with reduced benefit from chemotherapy in gallbladder cancer.
    Wang J; Bo X; Wang C; Xin Y; Nan L; Luo R; Chen L; Shi X; Suo T; Ni X; Liu H; Shen S; Li M; Lu P; Wang Y; Liu H
    Cancer Sci; 2020 Jan; 111(1):219-228. PubMed ID: 31729088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer.
    Fu H; Zhu Y; Wang Y; Liu Z; Zhang J; Xie H; Fu Q; Dai B; Ye D; Xu J
    Clin Cancer Res; 2018 Jul; 24(13):3069-3078. PubMed ID: 29514839
    [No Abstract]   [Full Text] [Related]  

  • 3. High infiltration of mast cells is associated with improved response to adjuvant chemotherapy in gallbladder cancer.
    Bo X; Wang J; Wang C; Nan L; Gao Z; Xin Y; Li M; Shen S; Liu H; Ni X; Suo T; Zhang D; Lu P; Wang Y; Liu H
    Cancer Sci; 2020 Mar; 111(3):817-825. PubMed ID: 31925976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma.
    Geng ZM; Cai ZQ; Zhang Z; Tang ZH; Xue F; Chen C; Zhang D; Li Q; Zhang R; Li WZ; Wang L; Si SB
    World J Gastroenterol; 2019 Oct; 25(37):5655-5666. PubMed ID: 31602165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-infiltrating neutrophils predict prognosis and adjuvant chemotherapeutic benefit in patients with biliary cancer.
    Wang J; Bo X; Suo T; Liu H; Ni X; Shen S; Li M; Xu J; Liu H; Wang Y
    Cancer Sci; 2018 Jul; 109(7):2266-2274. PubMed ID: 29723922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of immune cells in the tumor microenvironment and peripheral blood of gallbladder carcinoma patients.
    Zhang Y; Ma C; Wang M; Hou H; Cui L; Jiang C; Sun J; Qu X
    Clin Transl Oncol; 2017 Apr; 19(4):477-488. PubMed ID: 27718154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of tumor-infiltrating immune cells focusing on BTLA and Cbl-b in patients with gallbladder cancer.
    Oguro S; Ino Y; Shimada K; Hatanaka Y; Matsuno Y; Esaki M; Nara S; Kishi Y; Kosuge T; Hiraoka N
    Cancer Sci; 2015 Dec; 106(12):1750-60. PubMed ID: 26395180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Discussion on pT3 staging in TNM staging of AJCC 8(th) edition gallbladder carcinoma].
    Yang FC; Li JD; Duan AQ; Bo ZY; Shen NJ; Zhu B; Yu WL; Cui LJ; Wang X; Yu LH; Yin L; Fu XH; Zhang YJ; Qiu YH
    Zhonghua Wai Ke Za Zhi; 2019 Nov; 57(11):834-839. PubMed ID: 31694132
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic significance of neutrophil to lymphocyte ratio in patients with gallbladder carcinoma.
    Zhang L; Wang R; Chen W; Xu X; Dong S; Fan H; Liu C
    HPB (Oxford); 2016 Jul; 18(7):600-7. PubMed ID: 27346141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a novel immunotype for prediction of overall survival in patients with clear cell renal cell carcinoma.
    Yu D; Zhang X; Gao L; Qian S; Tang H; Shao N
    Front Oncol; 2022; 12():924072. PubMed ID: 36237315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallbladder carcinoma: a 28 year experience.
    Frezza EE; Mezghebe H
    Int Surg; 1997; 82(3):295-300. PubMed ID: 9372378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified staging classification of gallbladder carcinoma on the basis of the 8
    Wang J; Bo X; Shi X; Suo T; Xin Y; Nan L; Wang C; Ni X; Liu H; Pan H; Shen S; Li M; Lu P; Zhang D; Wang Z; Wang Y; Liu H
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):527-533. PubMed ID: 31630931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic and Neoadjuvant Chemotherapy Relevant Signatures.
    Ji F; Yuan JM; Gao HF; Xu AQ; Yang Z; Yang CQ; Zhang LL; Yang M; Li JQ; Zhu T; Cheng MY; Wu SY; Wang K
    Front Mol Biosci; 2021; 8():759495. PubMed ID: 34708079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can we assess the advancements of gallbladder cancer using red blood cell distribution width?
    Xie Y; Zhang L; Zhan L
    Medicine (Baltimore); 2019 Dec; 98(51):e18364. PubMed ID: 31860995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The survival prediction model of advanced gallbladder cancer based on Bayesian network: a multi-institutional study].
    Tang ZH; Geng ZM; Chen C; Si SB; Cai ZQ; Song TQ; Gong P; Jiang L; Qiu YH; He Y; Zhai WL; Li SP; Zhang YC; Yang Y
    Zhonghua Wai Ke Za Zhi; 2018 May; 56(5):342-349. PubMed ID: 29779309
    [No Abstract]   [Full Text] [Related]  

  • 16. A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy.
    Qian J; Qian Y; Wang J; Gu B; Pei D; He S; Zhu F; Røe OD; Xu J; Liu L; Gu Y; Guo R; Yin Y; Shu Y; Chen X
    Drug Des Devel Ther; 2016; 10():241-58. PubMed ID: 26966350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma.
    Zhang Y; Jiang C; Li J; Sun J; Qu X
    Clin Transl Oncol; 2015 Oct; 17(10):810-8. PubMed ID: 26077119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomogram to predict overall survival after gallbladder cancer resection in China.
    Bai Y; Liu ZS; Xiong JP; Xu WY; Lin JZ; Long JY; Miao F; Huang HC; Wan XS; Zhao HT
    World J Gastroenterol; 2018 Dec; 24(45):5167-5178. PubMed ID: 30568393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Threonine and tyrosine kinase may serve as a prognostic biomarker for gallbladder cancer.
    Xie Y; Lin JZ; Wang AQ; Xu WY; Long JY; Luo YF; Shi J; Liang ZY; Sang XT; Zhao HT
    World J Gastroenterol; 2017 Aug; 23(31):5787-5797. PubMed ID: 28883705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma.
    Kresl JJ; Schild SE; Henning GT; Gunderson LL; Donohue J; Pitot H; Haddock MG; Nagorney D
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):167-75. PubMed ID: 11777635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.